Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Telesis Bio Inc. (TBIO : OTC)

• Company Description    Telesis Bio is an automated multi-omic and synthetic biology solutions company. Its BioXp(R) system consolidates, automates and optimizes the entire synthesis, cloning and amplification workflow. Telesis Bio, formerly known as Codex DNA Inc., is based in SAN DIEGO. Number of Employees: 142

• Price / Volume Information    Yesterday's Closing Price: $0.30 Daily Weekly Monthly 20 Day Moving Average: 114 shares Shares Outstanding: 1.80 (millions) Market Capitalization: $0.54 (millions) Beta: 2.89 52 Week High: $6.17 52 Week Low: $0.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 500.00% 477.53% 12 Week -67.45% -72.62% Year To Date -25.00% -29.76%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10421 WATERIDGE CIRCLE SUITE 200 - SAN DIEGO,CA 92121 USA ph: 858-228-4115 fax: - ir@codexdna.com https://telesisbio.com

• General Corporate Information    Officers Todd R. Nelson - Chief Executive Officer and Director Frank R. Witney - Chair of the Board of Director William J. Kullback - Chief Financial Officer Andrea L. Jackson - Director Jami D. Nachtsheim - Director Peer Information Telesis Bio Inc. (CORR.) Telesis Bio Inc. (RSPI) Telesis Bio Inc. (CGXP) Telesis Bio Inc. (BGEN) Telesis Bio Inc. (GTBP) Telesis Bio Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 192003200 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/24 Next Expected EPS Date: 08/06/25 Share - Related Items Shares Outstanding: 1.80 Most Recent Split Date: 5.00 (0.06:1) Beta: 2.89 Market Capitalization: $0.54 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.04 EPS Growth vs. Year Ago Period: 42.45% vs. Previous Quarter: 45.52% Sales Growth vs. Year Ago Period: -71.85% vs. Previous Quarter: 1.03% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©